Cardiovascular Summit 2025 - Heart Failure Highlights
The Past, Present and Future

Bayer's Cardiovascular Summit took place in London on the 3rd and 4th of October 2025. Designed to offer education including expert perspectives and discussions on the management of Heart Failure, including differential diagnoses such as Cardiomyopathy and Amyloidosis, with a focus on Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Heart Failure (HF) Key Highlights
Here you can find short videos from our expert speakers, highlighting key points from the sessions discussing Heart Failure in depth, including;
- What is Heart Failure with Preserved Ejection Fraction (HFpEF)?
- Approaches to Patients with HFpEF
What is HFpEF?
Dr Kate Gatenby (5 Minutes)
HFpEF Approach
Dr Kate Gatenby (4 Minutes)
Please double click on the video to view it full screen.
Beyonttra▼(acoramidis) Prescribing Information.
Kerendia▼(finerenone) Prescribing Information.
This promotional meeting was initiated and funded by Bayer UK and is for UK Healthcare professionals only
Find out more about our Expert Speakers

Register for BayerPRO
Stay up to date on future events and webinars posted by registering to BayerPRO here.
Abbreviations:
ATTR-CM, Transthyretin Amyloid Cardiomyopathy; HF, Heart Failure.
PP-BEY-GB-0102 | May 2026



